Key Metrics
1.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.2
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Journal Specifications
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 3000 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Organisation for Research and Treatment of Cancer (EORTC); European Association for Cancer Research (EACR); European CanCer Organisation (ECCO); European Society of Mastology (EUSOMA) |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 9 |
| Article Processing Charges | USD 3000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in European Journal of Cancer, Supplement ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
540 POSTER Allogeneic MHC Class I conjugated to antitumor antibody can induce regression of syngenic tumor grafted in vivo
- 1 Oct 08
- European Journal of Cancer Supplements
-
Full paper
510 POSTER Phase I study of IMGN901 (BB-10901) in patients with CD56-positive solid tumours
- 1 Oct 08
- European Journal of Cancer Supplements
-
Full paper
554 POSTER Pharmacokinetic (PK) and pharmacodynamic (PD) results of Phase I studies of IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid malignancies
- 1 Oct 08
- European Journal of Cancer Supplements
-
Full paper
585 POSTER Phase I study of the safety and pharmacokinetics of an oral, film-coated (FC) tablet of CP-868,596, a PDGFR inhibitor, in patients with advanced cancers
- 1 Oct 08
- European Journal of Cancer Supplements
-
Full paper
586 POSTER Modulation of signaling through SEK1 and MKK7 differentially affects oxaliplatin sensitivity in hypoxic colon cancer cell lines
- 1 Oct 08
- European Journal of Cancer Supplements
-
Full paper
550 POSTER Designing nanovectors for siRNA delivery: coupled experimental/modeling investigations
- 1 Oct 08
- European Journal of Cancer Supplements
Scite analysis
Powered by scite_
15.2k articles received 14.3k citations see all
- 556 Supporting
- 13,155 Mentioning
- 71 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
What is the eISSN & pISSN for European Journal of Cancer, Supplement ?
For European Journal of Cancer, Supplement,eISSN is 1878-1217 and pISSN is1359-6349.
What is Citescore for European Journal of Cancer, Supplement ?
Citescore for European Journal of Cancer, Supplement is 1.2.
What is SNIP score for European Journal of Cancer, Supplement ?
SNIP score for European Journal of Cancer, Supplement is 0.2.
Who is the publisher of European Journal of Cancer, Supplement ?
Elsevier is the publisher of European Journal of Cancer, Supplement.